Enveric Biosciences Inc vs Rocket Lab USA Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Rocket Lab USA Inc trades at $79.73 (market cap $50.01B). The key difference: Rocket Lab USA Inc is far larger — about 8066.1× Enveric Biosciences Inc's market cap, and Rocket Lab USA Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | RKLB | |
|---|---|---|
Market Cap | $6.20M | $50.01B |
Sector | Health | Technology |
52-Week High | $17.40 | $150.23 |
52-Week Low | $1.27 | $39.48 |
Enterprise Value | $1.30M | $47.84B |
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →